2025-04-15 - Analysis Report
## Procter & Gamble Co. (PG) Stock Review

**0) Introduction:** This report analyzes Procter & Gamble Co. (PG), a leading consumer goods company, based on provided financial data.  We'll compare its performance against the S&P 500 (VOO), assess recent price movements, and examine key financial indicators.

**1) Performance Comparison with S&P 500:**

Procter & Gamble's cumulative return is 64.09%, while the S&P 500's is 66.69%.  This represents a difference of -2.6 percentage points. The relative divergence of -2.6% places PG at the 46.3rd percentile of its historical range (max: 29.7%, min: -30.5%).  This indicates PG underperformed the S&P 500 slightly, but its performance remains relatively close to the market benchmark.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 22.0% | 7.9% | -7.0% | 0.0 | 177.8 |
| 2016-2018  | 4.0% | 56.9% | -14.0% | 0.0 | 184.2 |
| 2017-2019  | 32.0% | 56.9% | 3.0% | 0.5 | 257.3 |
| 2018-2020  | 45.0% | 59.5% | 20.0% | 0.3 | 293.7 |
| 2019-2021  | 62.0% | 59.5% | 8.0% | 0.3 | 354.0 |
| 2020-2022  | 25.0% | 74.7% | 19.0% | 0.3 | 336.1 |
| 2021-2023  | 27.0% | 74.7% | 10.0% | 0.3 | 333.2 |
| 2022-2024  | 3.0% | 74.7% | -14.0% | 0.3 | 390.7 |
| 2023-2025  | 1.0% | 70.4% | -14.0% | 0.2 | 396.6 |

The data shows varying CAGR and Alpha values, suggesting periods of both outperformance and underperformance relative to the benchmark.  The Beta values generally indicate low market sensitivity.

**2) Recent Price Movement:**

* **Closing Price:** $169.13
* **5-day Moving Average:** $164.06
* **20-day Moving Average:** $166.48
* **60-day Moving Average:** $168.16

The price is above all three moving averages, suggesting a potential upward trend, although the difference isn't significant. The recent increase of $1.33 from the previous close indicates a minor positive momentum.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4585 (High Risk category)  This suggests a higher level of market volatility.
* **RSI:** 58.32 (Slightly above the neutral 50 level) This implies neither overbought nor oversold conditions, but leans towards bullish momentum.
* **PPO:** 0.0363 (Positive) This indicates a bullish signal.
* **20-day Relative Divergence Change:** -15.0% (Short-term downward trend)  This counteracts the positive momentum suggested by other indicators.
* **Expected Return:** 9.4% (over S&P 500 for long-term investment) This shows potential for outperformance over a longer timeframe.  The price change of $1.33 isn't significant enough to classify as a sharp upward movement.


**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2025-01-22 | 1.94 | $21.88 B      |
| 2024-10-18 | 1.65 | $21.74 B      |
| 2024-04-19 | 1.56 | $20.20 B      |
| 2024-01-23 | 1.44 | $21.44 B      |
| 2025-01-22 | 1.44 | $21.44 B      | *(Duplicate entry - likely an error)*

Revenue is relatively stable, with some fluctuation. EPS shows a notable increase in the most recent quarter (2025-01-22), indicating strong profitability.  The duplicate entry needs clarification.

**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|---------------|---------------|
| 2024-12-31 | $21.88B      | 52.39%        |
| 2024-09-30 | $21.74B      | 52.06%        |
| 2024-06-30 | $20.53B      | 49.60%        |
| 2024-03-31 | $20.20B      | 51.20%        |
| 2023-12-31 | $21.44B      | 52.69%        |

Revenue shows slight fluctuations, but profit margins remain consistently high, indicating strong profitability and operational efficiency.


**Capital and Profitability:**

| Quarter | Equity       | ROE     |
|---------|---------------|---------|
| 2024-12-31 | $51.17B      | 9.05%   |
| 2024-09-30 | $51.84B      | 7.64%   |
| 2024-06-30 | $50.29B      | 6.24%   |
| 2024-03-31 | $50.06B      | 7.50%   |
| 2023-12-31 | $48.53B      | 7.15%   |

Equity shows some variability, and ROE also fluctuates, but generally remains healthy, indicating reasonable returns on investment.

**6) Overall Analysis:**

PG demonstrates consistent revenue and high profit margins, indicating a stable and profitable business.  While its recent performance slightly lagged the S&P 500,  long-term projections show potential for outperformance. The high MRI suggests higher market risk, but positive PPO and a relatively high RSI indicate bullish momentum.  However, the recent negative relative divergence should be monitored.  The strong EPS growth in the most recent quarter is a positive signal.  Further investigation is needed to clarify the duplicate earnings data entry.  Overall, PG appears to be a relatively stable investment with potential for long-term growth, although investors should be aware of the current higher market risk.
